SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-040907
Filing Date
2021-08-04
Accepted
2021-08-04 16:56:14
Documents
83
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q txmd-10q_20210630.htm   iXBRL 10-Q 2140455
2 EX-31.1 txmd-ex311_6.htm EX-31.1 17704
3 EX-31.2 txmd-ex312_7.htm EX-31.2 17722
4 EX-32.1 txmd-ex321_27.htm EX-32.1 7917
5 EX-32.2 txmd-ex322_26.htm EX-32.2 7874
6 GRAPHIC ge3zpigpxadx000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-21-040907.txt   9111077

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA txmd-20210630.xsd EX-101.SCH 66091
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txmd-20210630_cal.xml EX-101.CAL 54312
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txmd-20210630_def.xml EX-101.DEF 196264
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20210630_lab.xml EX-101.LAB 420242
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20210630_pre.xml EX-101.PRE 349931
12 EXTRACTED XBRL INSTANCE DOCUMENT txmd-10q_20210630_htm.xml XML 2067243
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 211144884
SIC: 2834 Pharmaceutical Preparations